TRIB

TRINITY BIOTECH PLC TRIB

NasdaqMid CapHealthcare
InternationalScored off the official board: an annual-only filer, so this data lags a domestic quarterly filer.

13F Pro quality score

Rank #2,712 of 2,925

Why it scores 22Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$43.78M

Quarter to Dec 31

Net income

$-37.38M

Quarter to Dec 31

Free cash flow

$-6.02M

Quarter to Dec 31

Operating margin

-36.1%

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$379.5K total
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC
$251.0K+23.3%
Williams & Novak, LLC
$54.6K+30.6%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$10.4KNew
Moss Adams Wealth Advisors LLC
$10.0K0.0%
Cambridge Investment Research Advisors, Inc.
$9.0K0.0%
INSPIRION WEALTH ADVISORS, LLC
$8.9K0.0%
RAYMOND JAMES FINANCIAL INC
$7.9K0.0%
BECKER CAPITAL MANAGEMENT INC
$7.0K0.0%
LPL Financial LLC
$6.9K+17.5%
GEODE CAPITAL MANAGEMENT, LLC
$4.9K-24.3%
RHUMBLINE ADVISERS
$3.6K+68.9%
OSAIC HOLDINGS, INC.
$1.4KNew
JONES FINANCIAL COMPANIES LLLP
$1.3K-4.2%
WELLS FARGO & COMPANY/MN
$9720.0%
Farther Finance Advisors, LLC
$7780.0%
UBS Group AG
$431+9.9%
MORGAN STANLEY
$156-0.5%
SIMPLEX TRADING, LLC
$137-36.2%
ATWOOD & PALMER INC
$80.0%
CoreCap Advisors, LLC
$00.0%
See all 20 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

Operating Margin

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/TRIB

Earnings Per Share

13fpro.ai/company/TRIB

Loading ratio trend…

TRIB key financials by period

Reported revenue, net income and operating margin by fiscal year, from TRINITY BIOTECH PLC's annual filings on SEC EDGAR.

TRINITY BIOTECH PLC reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$43.8M$-37.4M-36.1%
FY 2024$61.6M$-31.8M-34.4%
FY 2023$56.8M$-24.0M-47.6%
FY 2022$62.5M$-41.0M-30.9%
FY 2021$81.1M$875.0K4.9%
FY 2020$102.0M$-6.4M0.1%
Source: TRIB filings on SEC EDGAR →

Companies similar to TRIB

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

About TRINITY BIOTECH PLC (TRIB): stock profile, AI score and financials

TRINITY BIOTECH PLC (TRIB) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TRIB at 22.1/100 on a composite quality score built from its SEC filings, placing it at rank #2,712 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), TRINITY BIOTECH PLC reports quarterly revenue of $43.8M, net income of $-37.4M, an operating margin of -36.1%. Top institutional holders of TRIB by reported 13-F value include HUNTER ASSOCIATES INVESTMENT MANAGEMENT, Williams & Novak, SUSQUEHANNA INTERNATIONAL GROUP, LLP, based on the most recent SEC filings. TRIB trades on the Nasdaq exchange and files with the SEC under CIK 888721. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TRIB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TRINITY BIOTECH PLC directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 888721 →